Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Reid

Showing results (401-410 of 589) with videos related to

Pageof 59
Sort By:
Current Medical Research and Opinion|December 25, 2019
The cost-effectiveness of guideline-driven use of drug-eluting stents: propensity-score matched analysis of a seven-year multicentre experienceThathya V Ariyaratne, Zanfina Ademi, Richard Ofori-Asenso, et al.
International Journal of Cardiology|September 16, 2016
Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarctionMatias B Yudi, Jay Ramchand, Omar Farouque, et al.
BMJ Open|March 1, 2023
Registry randomised trials: a methodological perspectiveDorota A Doherty, Steven Y C Tong, Jennifer Reilly, et al.
International Journal of Cardiology|March 21, 2020
Long-term outcomes following percutaneous coronary intervention to an unprotected left main coronary artery in cardiogenic shockJulian Yeoh, Nick Andrianopoulos, Christopher M Reid, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Access route selection for percutaneous coronary intervention among Vietnamese patients: Implications for in-hospital costs and outcomesHoa T T Vu, Richard Norman, Ngoc M Pham, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 27, 2023
Real-world long-term survival after non-emergent percutaneous coronary intervention to unprotected left main coronary artery - From the Melbourne Interventional Group (MIG) registryJulian Gin, Julian Yeoh, Garry Hamilton, et al.
The American Journal of Cardiology|June 20, 2021
Comparison of Outcomes of Coronary Artery Disease Treated by Percutaneous Coronary Intervention in 3 Different Age Groups (<45, 46-65, and >65 Years)Samer Noaman, Diem Dinh, Christopher M Reid, et al.
International Journal of Geriatric Psychiatry|April 17, 2019
Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United StatesMohammadreza Mohebbi, Bruno Agustini, Robyn L Woods, et al.
American Heart Journal|April 21, 2019
Trends and predictors of recurrent acute coronary syndrome hospitalizations and unplanned revascularization after index acute myocardial infarction treated with percutaneous coronary interventionMatias B Yudi, David J Clark, Omar Farouque, et al.
Journal of Multimorbidity and Comorbidity|June 16, 2025
Harnessing telehealth for multimorbidity management in rural and remote areas: A scoping review of interventions, outcomes, and implementation dynamicsSage M C Ishimwe, Delia Hendrie, Timothy A Carey, et al.
Pageof 59

Showing results (401-410 of 589) with videos related to

Sort By:
Pageof 59
Current Medical Research and Opinion|December 25, 2019
The cost-effectiveness of guideline-driven use of drug-eluting stents: propensity-score matched analysis of a seven-year multicentre experienceThathya V Ariyaratne, Zanfina Ademi, Richard Ofori-Asenso, et al.
International Journal of Cardiology|September 16, 2016
Impact of door-to-balloon time on long-term mortality in high- and low-risk patients with ST-elevation myocardial infarctionMatias B Yudi, Jay Ramchand, Omar Farouque, et al.
BMJ Open|March 1, 2023
Registry randomised trials: a methodological perspectiveDorota A Doherty, Steven Y C Tong, Jennifer Reilly, et al.
International Journal of Cardiology|March 21, 2020
Long-term outcomes following percutaneous coronary intervention to an unprotected left main coronary artery in cardiogenic shockJulian Yeoh, Nick Andrianopoulos, Christopher M Reid, et al.
The Lancet Regional Health. Western Pacific|July 30, 2021
Access route selection for percutaneous coronary intervention among Vietnamese patients: Implications for in-hospital costs and outcomesHoa T T Vu, Richard Norman, Ngoc M Pham, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 27, 2023
Real-world long-term survival after non-emergent percutaneous coronary intervention to unprotected left main coronary artery - From the Melbourne Interventional Group (MIG) registryJulian Gin, Julian Yeoh, Garry Hamilton, et al.
The American Journal of Cardiology|June 20, 2021
Comparison of Outcomes of Coronary Artery Disease Treated by Percutaneous Coronary Intervention in 3 Different Age Groups (<45, 46-65, and >65 Years)Samer Noaman, Diem Dinh, Christopher M Reid, et al.
International Journal of Geriatric Psychiatry|April 17, 2019
Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United StatesMohammadreza Mohebbi, Bruno Agustini, Robyn L Woods, et al.
American Heart Journal|April 21, 2019
Trends and predictors of recurrent acute coronary syndrome hospitalizations and unplanned revascularization after index acute myocardial infarction treated with percutaneous coronary interventionMatias B Yudi, David J Clark, Omar Farouque, et al.
Journal of Multimorbidity and Comorbidity|June 16, 2025
Harnessing telehealth for multimorbidity management in rural and remote areas: A scoping review of interventions, outcomes, and implementation dynamicsSage M C Ishimwe, Delia Hendrie, Timothy A Carey, et al.
Pageof 59